Telmisartan 40 MG Oral Tablet — RxCUI 205304
RxNorm drug concept · Semantic clinical drug
RxCUI 205304
Semantic clinical drug · SCD
● Current RxNorm concept 67 FDA products
207 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI205304
Official nameTelmisartan 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped67
Package NDCs mapped207
Reported Medicaid activity (SDUD)104,888 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Telmisartan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats high blood pressure. It's also used to lower the risk of heart attack, stroke, or cardiovascular death in people 55 or older at high risk who can't take ACE inhibitors. Y...
- Take it by mouth once a day, with or without food. Following the same routine each day helps. Full blood pressure effect usually takes about 4 weeks, so don't be discouraged early...
- Most people have few problems. Back pain, sinus symptoms, diarrhea, and colds were the more common ones in studies. Call your doctor right away if you notice swelling of the face,...
- No. It can seriously harm or even kill an unborn baby, especially in the second and third trimesters. Let your doctor know right away if you become pregnant, and do not breastfeed...
🕸️ Concept Web — How Telmisartan 40 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Telmisartan 40 MG Oral Tablet
RxCUI 205304 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Telmisartan
73494IN
-
Telmisartan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Micardis
218353BN
-
Micardis
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Telmisartan Oral Tablet
374024SCDF -
Telmisartan Oral Product
1161480SCDG -
Telmisartan Pill
1161481SCDG -
Telmisartan Oral Tablet [Micardis]
368146SBDF -
Micardis Oral Product
1178058SBDG -
Micardis Pill
1178059SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Telmisartan Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Telmisartan 40 MG
316764SCDC -
Telmisartan 40 MG Oral Tablet [Micardis]
213431SBD -
Telmisartan 40 MG [Micardis]
573320SBDC
-
Telmisartan 40 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Telmisartan 40 MG
SCDC · 316764 -
Telmisartan Oral Tablet
SCDF · 374024 -
Telmisartan Oral Product
SCDG · 1161480 -
Telmisartan Pill
SCDG · 1161481
Brand-Name Concepts
-
Telmisartan 40 MG Oral Tablet [Micardis]
SBD · 213431 -
Telmisartan 40 MG [Micardis]
SBDC · 573320 -
Telmisartan Oral Tablet [Micardis]
SBDF · 368146 -
Micardis Oral Product
SBDG · 1178058 -
Micardis Pill
SBDG · 1178059 -
Micardis
BN · 218353
📦 FDA Products & Package NDCs
67 products · 207 package NDCs
207 package NDCs map to RxCUI 205304 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-2920-77 | 90 TABLET in 1 BOTTLE, PLASTIC (0378-2920-77) | Telmisartan | Mylan Pharmaceuticals Inc. | 2014-07-07 |
| 00378-2920-93 | 30 TABLET in 1 BOTTLE, PLASTIC (0378-2920-93) | Telmisartan | Mylan Pharmaceuticals Inc. | 2014-07-07 |
| 00378-2921-77 | 90 TABLET in 1 BOTTLE, PLASTIC (0378-2921-77) | Telmisartan | Mylan Pharmaceuticals Inc. | 2014-07-07 |
| 00378-2921-93 | 30 TABLET in 1 BOTTLE, PLASTIC (0378-2921-93) | Telmisartan | Mylan Pharmaceuticals Inc. | 2014-07-07 |
| 00378-2922-77 | 90 TABLET in 1 BOTTLE, PLASTIC (0378-2922-77) | Telmisartan | Mylan Pharmaceuticals Inc. | 2014-07-07 |
| 00378-2922-93 | 30 TABLET in 1 BOTTLE, PLASTIC (0378-2922-93) | Telmisartan | Mylan Pharmaceuticals Inc. | 2014-07-07 |
| 33342-0118-07 | 30 TABLET in 1 CONTAINER (33342-118-07) | Telmisartan | Macleods Pharmaceuticals Limited | 2025-01-15 |
| 33342-0118-10 | 90 TABLET in 1 CONTAINER (33342-118-10) | Telmisartan | Macleods Pharmaceuticals Limited | 2025-01-15 |
| 33342-0119-07 | 30 TABLET in 1 CONTAINER (33342-119-07) | Telmisartan | Macleods Pharmaceuticals Limited | 2025-01-15 |
| 33342-0119-10 | 90 TABLET in 1 CONTAINER (33342-119-10) | Telmisartan | Macleods Pharmaceuticals Limited | 2025-01-15 |
| 33342-0120-07 | 30 TABLET in 1 CONTAINER (33342-120-07) | Telmisartan | Macleods Pharmaceuticals Limited | 2025-01-15 |
| 33342-0120-10 | 90 TABLET in 1 CONTAINER (33342-120-10) | Telmisartan | Macleods Pharmaceuticals Limited | 2025-01-15 |
| 42291-0790-30 | 30 TABLET in 1 BOTTLE (42291-790-30) | Telmisartan | AvKARE | 2017-12-20 |
| 42291-0791-30 | 30 TABLET in 1 BOTTLE (42291-791-30) | Telmisartan | AvKARE | 2017-12-20 |
| 42291-0792-30 | 30 TABLET in 1 BOTTLE (42291-792-30) | Telmisartan | AvKARE | 2017-12-20 |
| 42571-0226-05 | 500 TABLET in 1 BOTTLE (42571-226-05) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0226-10 | 1000 TABLET in 1 BOTTLE (42571-226-10) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0226-11 | 10 BLISTER PACK in 1 CARTON (42571-226-11) / 10 TABLET in 1... | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0226-30 | 30 TABLET in 1 BOTTLE (42571-226-30) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0226-41 | 3 TABLET in 1 CARTON (42571-226-41) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0226-90 | 90 TABLET in 1 BOTTLE (42571-226-90) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0227-05 | 500 TABLET in 1 BOTTLE (42571-227-05) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0227-10 | 1000 TABLET in 1 BOTTLE (42571-227-10) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0227-11 | 10 BLISTER PACK in 1 CARTON (42571-227-11) / 10 TABLET in 1... | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0227-30 | 30 TABLET in 1 BOTTLE (42571-227-30) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0227-41 | 3 TABLET in 1 CARTON (42571-227-41) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0227-90 | 90 TABLET in 1 BOTTLE (42571-227-90) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0228-05 | 500 TABLET in 1 BOTTLE (42571-228-05) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0228-10 | 1000 TABLET in 1 BOTTLE (42571-228-10) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0228-11 | 10 BLISTER PACK in 1 CARTON (42571-228-11) / 10 TABLET in 1... | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0228-30 | 30 TABLET in 1 BOTTLE (42571-228-30) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0228-41 | 3 TABLET in 1 CARTON (42571-228-41) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 42571-0228-90 | 90 TABLET in 1 BOTTLE (42571-228-90) | TELMISARTAN | Micro Labs Limited | 2018-01-01 |
| 43547-0283-03 | 30 TABLET in 1 BOTTLE (43547-283-03) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 43547-0283-09 | 90 TABLET in 1 BOTTLE (43547-283-09) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 43547-0283-50 | 500 TABLET in 1 BOTTLE (43547-283-50) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 43547-0284-03 | 30 TABLET in 1 BOTTLE (43547-284-03) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 43547-0284-09 | 90 TABLET in 1 BOTTLE (43547-284-09) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 43547-0284-50 | 500 TABLET in 1 BOTTLE (43547-284-50) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 43547-0285-03 | 30 TABLET in 1 BOTTLE (43547-285-03) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 43547-0285-09 | 90 TABLET in 1 BOTTLE (43547-285-09) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 43547-0285-50 | 500 TABLET in 1 BOTTLE (43547-285-50) | Telmisartan | Solco Healthcare US, LLC | 2017-08-20 |
| 46708-0608-30 | 30 TABLET in 1 BOTTLE (46708-608-30) | Telmisartan | Alembic Pharmaceuticals Limited | 2016-06-25 |
| 46708-0608-91 | 1000 TABLET in 1 BOTTLE (46708-608-91) | Telmisartan | Alembic Pharmaceuticals Limited | 2016-06-25 |
| 46708-0609-30 | 30 TABLET in 1 BOTTLE (46708-609-30) | Telmisartan | Alembic Pharmaceuticals Limited | 2016-06-25 |
| 46708-0609-91 | 1000 TABLET in 1 BOTTLE (46708-609-91) | Telmisartan | Alembic Pharmaceuticals Limited | 2016-06-25 |
| 46708-0610-30 | 30 TABLET in 1 BOTTLE (46708-610-30) | Telmisartan | Alembic Pharmaceuticals Limited | 2016-06-25 |
| 46708-0610-91 | 1000 TABLET in 1 BOTTLE (46708-610-91) | Telmisartan | Alembic Pharmaceuticals Limited | 2016-06-25 |
| 50090-5490-00 | 90 TABLET in 1 BOTTLE, PLASTIC (50090-5490-0) | Telmisartan | A-S Medication Solutions | 2021-03-16 |
| 53746-0291-30 | 30 TABLET in 1 BOTTLE (53746-291-30) | Telmisartan | Amneal Pharmaceuticals of New York LLC | 2016-09-25 |
Observed labelers:
Cadila Pharmaceuticals Limited (21) ·
Modavar Pharmaceuticals LLC (21) ·
Micro Labs Limited (18) ·
Zydus Lifesciences Limited (18) ·
Zydus Pharmaceuticals USA Inc. (18) ·
Glenmark Pharmaceuticals Inc., USA (15)
· +17 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.